AI Architecture for predicting cancer biomarkers

Genomics that inform drug development

  • AI Architecture for predicting cancer biomarkers

    • Initial biomarker: HRD breast and ovarian cancer; pancreatic cancer
    • Future biomarkers:
      KRAS, EGFR, BRCA 1/2,
      HR gene panel, MMRD/MSI, mutational signatures*, various cancers

  • 9p Loss Test for HPV negative head and neck cancers

    • Collaboration and Commercialization agreement with leading Oncology CLIA lab

  • Mapping Hot Spot Mutations

    • Future development and/or partnership

*Alexandrov, et al., Nature 2013; Alexandrov, et al., Nature 2020